Sun Pharmaceutical Industries Limited (SUNPHARMA.BO)
INR 1676.35
(1.25%)
INR 1676.35
(1.25%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 854.62 Billion INR | 5.84% |
| 2022 | 807.43 Billion INR | 15.68% |
| 2021 | 697.99 Billion INR | 3.15% |
| 2020 | 676.66 Billion INR | -0.86% |
| 2019 | 682.52 Billion INR | 5.5% |
| 2018 | 646.93 Billion INR | 0.28% |
| 2017 | 645.16 Billion INR | 5.06% |
| 2016 | 614.1 Billion INR | 10.59% |
| 2015 | 555.3 Billion INR | 10.71% |
| 2014 | 501.6 Billion INR | 70.78% |
| 2013 | 293.7 Billion INR | 42.7% |
| 2012 | 205.82 Billion INR | 24.94% |
| 2011 | 164.74 Billion INR | 33.14% |
| 2010 | 123.73 Billion INR | 36.39% |
| 2009 | 90.72 Billion INR | 9.79% |
| 2008 | 82.63 Billion INR | 35.94% |
| 2007 | 60.78 Billion INR | 40.55% |
| 2006 | 43.25 Billion INR | 9.36% |
| 2005 | 39.54 Billion INR | 19.19% |
| 2004 | 33.18 Billion INR | 117.88% |
| 2003 | 15.22 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2024 Q2 | 881.15 Billion INR | 0.0% |
| 2023 Q2 | 794.41 Billion INR | 0.0% |
| 2023 Q4 | 854.62 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 854.62 Billion INR | 5.84% |
| 2023 Q1 | - INR | -100.0% |
| 2022 FY | 807.43 Billion INR | 15.68% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 744.55 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 807.43 Billion INR | 0.0% |
| 2021 Q4 | 697.99 Billion INR | 0.0% |
| 2021 FY | 697.99 Billion INR | 3.15% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 690.54 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 FY | 676.66 Billion INR | -0.86% |
| 2020 Q4 | 676.66 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 676.71 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 682.52 Billion INR | 5.5% |
| 2019 Q4 | 682.52 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 651.67 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 646.93 Billion INR | 0.28% |
| 2018 Q4 | 646.93 Billion INR | 0.0% |
| 2018 Q2 | 707.66 Billion INR | 0.0% |
| 2017 FY | 645.16 Billion INR | 5.06% |
| 2017 Q4 | 645.16 Billion INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q2 | 643.93 Billion INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2016 Q4 | 614.1 Billion INR | 0.0% |
| 2016 FY | 614.1 Billion INR | 10.59% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q2 | 604.4 Billion INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q2 | 507.85 Billion INR | 0.0% |
| 2015 Q4 | 555.3 Billion INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 555.3 Billion INR | 10.71% |
| 2014 Q4 | 501.6 Billion INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q2 | 315.62 Billion INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 FY | 501.6 Billion INR | 70.78% |
| 2013 FY | 293.7 Billion INR | 42.7% |
| 2013 Q4 | 293.7 Billion INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q2 | 254.9 Billion INR | 0.0% |
| 2012 FY | 205.82 Billion INR | 24.94% |
| 2012 Q4 | 205.82 Billion INR | 0.0% |
| 2012 Q2 | 174.57 Billion INR | 0.0% |
| 2011 Q4 | 164.74 Billion INR | 0.0% |
| 2011 FY | 164.74 Billion INR | 33.14% |
| 2010 FY | 123.73 Billion INR | 36.39% |
| 2009 FY | 90.72 Billion INR | 9.79% |
| 2008 FY | 82.63 Billion INR | 35.94% |
| 2007 FY | 60.78 Billion INR | 40.55% |
| 2006 FY | 43.25 Billion INR | 9.36% |
| 2005 FY | 39.54 Billion INR | 19.19% |
| 2004 FY | 33.18 Billion INR | 117.88% |
| 2003 FY | 15.22 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Bal Pharma Limited | 3.2 Billion INR | -26574.724% |
| Achyut Healthcare Limited | 309.52 Million INR | -276012.457% |
| Alkem Laboratories Limited | 155.74 Billion INR | -448.722% |
| Divi's Laboratories Limited | 154.7 Billion INR | -452.443% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | -495.202% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | -2898.264% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -47865.777% |
| Mankind Pharma Limited | 119.63 Billion INR | -614.378% |
| Medicamen Biotech Limited | 2.94 Billion INR | -28917.447% |
| Medico Remedies Limited | 961.95 Million INR | -88743.093% |
| Megasoft Limited | 3.65 Billion INR | -23256.914% |
| Procter & Gamble Health Limited | 7.94 Billion INR | -10658.709% |
| Piramal Pharma Limited | 153.11 Billion INR | -458.15% |
| Sequent Scientific Limited | 15.4 Billion INR | -5448.154% |
| Sigachi Industries Limited | 6.94 Billion INR | -12211.76% |
| Ajanta Pharma Limited | 46.38 Billion INR | -1742.512% |
| Brooks Laboratories Limited | 904.45 Million INR | -94391.129% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | -3209.821% |
| Themis Medicare Limited | 5.66 Billion INR | -14988.346% |
| Unichem Laboratories Limited | 31.69 Billion INR | -2596.548% |
| Hester Biosciences Limited | 6.62 Billion INR | -12803.037% |
| Venus Remedies Limited | 6.26 Billion INR | -13534.14% |
| Indoco Remedies Limited | 21.44 Billion INR | -3884.785% |
| Ind-Swift Limited | 6.54 Billion INR | -12958.308% |
| Aarti Drugs Limited | 24.32 Billion INR | -3413.579% |
| Alpa Laboratories Limited | 1.82 Billion INR | -46697.768% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | -7827.703% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | -120.539% |
| Granules India Limited | 55.2 Billion INR | -1447.965% |
| Gufic Biosciences Limited | 10.92 Billion INR | -7722.391% |
| Hikal Limited | 24.87 Billion INR | -3336.191% |
| RPG Life Sciences Limited | 5.12 Billion INR | -16563.654% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | -3691.464% |
| Windlas Biotech Limited | 6.26 Billion INR | -13547.726% |
| ZIM Laboratories Limited | 4.46 Billion INR | -19026.816% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | -7235.2% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | -3707.827% |
| Jubilant Pharmova Limited | 115.48 Billion INR | -640.034% |
| Aurobindo Pharma Limited | 450.71 Billion INR | -89.616% |
| Bajaj HealthCare Limited | 7.65 Billion INR | -11069.754% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -181416.523% |
| Ipca Laboratories Limited | 111.01 Billion INR | -669.847% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -56547.191% |
| Laurus Labs Limited | 83.87 Billion INR | -918.989% |
| NATCO Pharma Limited | 69.06 Billion INR | -1137.463% |
| Nectar Lifesciences Limited | 21.91 Billion INR | -3800.533% |
| Shilpa Medicare Limited | 30.93 Billion INR | -2662.924% |
| Solara Active Pharma Sciences Limited | 23.5 Billion INR | -3535.233% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | -467.445% |
| Wanbury Limited | 3.43 Billion INR | -24780.523% |
| Wockhardt Limited | 76.49 Billion INR | -1017.308% |
| Strides Pharma Science Limited | 58.39 Billion INR | -1363.467% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | -6940.539% |
| Suven Life Sciences Limited | 2.84 Billion INR | -29897.217% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -23195.096% |
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | -1225.915% |
| Eris Lifesciences Limited | 70.48 Billion INR | -1112.439% |
| Lupin Limited | 239.97 Billion INR | -256.137% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -16493.445% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -21019.472% |
| Valiant Laboratories Limited | 3.42 Billion INR | -24839.028% |
| Zydus Lifesciences Limited | 292.8 Billion INR | -191.873% |
| FDC Limited | 24.68 Billion INR | -3362.714% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | -2039.712% |
| Novartis India Limited | 9.24 Billion INR | -9139.93% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -39269.664% |
| Neuland Laboratories Limited | 18.32 Billion INR | -4563.576% |
| Morepen Laboratories Limited | 12.93 Billion INR | -6508.61% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -35500.396% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -25531.877% |